Armata Pharmaceuticals (ARMP) Shareholder's Equity Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.01% |
| Dec 31, 2025 | -68.52% |
| Sep 30, 2025 | -42.53% |
| Jun 30, 2025 | -34.15% |
| Mar 31, 2025 | -29.24% |
| Dec 31, 2024 | -39.54% |
| Sep 30, 2024 | -36.91% |
| Jun 30, 2024 | -32.20% |
| Mar 31, 2024 | -74.73% |
| Dec 31, 2023 | -43.89% |
| Sep 30, 2023 | -27.79% |
| Jun 30, 2023 | 10.62% |
| Mar 31, 2023 | 8.83% |
| Dec 31, 2022 | 8.19% |
| Sep 30, 2022 | 36.11% |
| Jun 30, 2022 | 40.13% |
| Mar 31, 2022 | 56.06% |
| Dec 31, 2021 | 21.17% |
| Sep 30, 2021 | 5.44% |
| Jun 30, 2021 | 5.90% |
| Mar 31, 2021 | 30.76% |
| Dec 31, 2020 | 8.20% |
| Sep 30, 2020 | 9.47% |
| Jun 30, 2020 | 17.76% |
| Mar 31, 2020 | 66.73% |
| Dec 31, 2019 | 33.53% |
| Sep 30, 2019 | 32.93% |
| Jun 30, 2019 | 26.68% |
| Mar 31, 2019 | 16.18% |
| Dec 31, 2018 | 18.53% |